🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

K Navigator was built to take the heavy lifting out of exploring complex datasets, so scientists can focus on making breakthroughs faster. That's why we love hearing this kind of feedback from researchers using K Navigator in the real world. Learn more about K-Navigator:

Join expert pathologists Magali Lacroix-Triki from Gustave Roussy, Savitri Krishnamurthy from MD Anderson Cancer Center, and Valentin Gaury for our upcoming webinar ‘Breast Cancer Recurrence Risk Assessment from Digitized H&E with RlapsRisk® BC, a Clinically Validated AI Prognostic

✨ Today marks 9 years of Owkin! From day one to today, we’re sharing snapshots from each year to reflect on how far we’ve come. It’s all thanks to our incredible Owkinautes and external partners who made it possible. From groundbreaking collaborations to the recent launch of

We’re proud to share our latest publication on MOSAIC — our large-scale, multi-center initiative mapping tumor complexity across thousands of cancer patients using spatial and single-cell omics, histology, and AI. MOSAIC integrates: 🔬 Spatial & single-cell transcriptomics 🧬

Spatial omics is set to transform our understanding of cancer by revealing how different cell types interact within the tumor microenvironment. Co-founded by Owkin, Mosaic research unites leading academic centers and industry partners to build a groundbreaking dataset. 👩‍💻 Visit

Despite what you've heard, when it comes to AI, bigger models are not always better. 🔬 Check out our Nature feature ‘AI in digital pathology: smaller models, bigger impact' to read how smaller, faster, and more efficient AI foundation models can transform cancer diagnostics,

A recent ESMO - Eur. Oncology paper, published in the Annals of Oncology, offers a comprehensive overview of how the AI landscape in oncology and pathology has evolved. While AI has immense potential to transform cancer care, barriers such as inadequate infrastructure, regulatory frameworks,

🔍 Accelerating discovery. Reducing bottlenecks. Unlocking new therapeutic frontiers. Powered by agentic AI, K Navigator allows researchers to move faster — from multimodal data to real biological insights. 👇 Read why Prof. FabriceAndre calls it a game-changer.

🎉 Thrilled to share that two of our papers have been accepted to MICCAI 2025! 📄 H0-mini – our collaboration with Bioptimus – shows how distillation techniques can shrink foundation models for histopathology by several orders of magnitude while preserving performance and

Join Victor Aubert, Diagnostics Product Director, for his flash talk at AI in Oncology 2025 by IHU PRISM. The combination of AI, digital pathology, and molecular analysis is creating a new paradigm in cancer diagnostics. Learn how Owkin is leveraging these technologies to enable

🎙️ New podcast out now! Dr. Meriem Sefta, Chief Diagnostics Officer at Owkin and Amanda Coble Senior Director of Product at Proscia sat down with the people of pathology podcast for a deep dive into diagnostic innovation and the power of partnership. Discover: 🔬 AI and deep

🧑‍💻🦠Science is in its most exciting era but with funding cuts and a lack of resources, researchers are struggling to keep up. Every day brings a stream of new papers, data, and ideas, and in the middle of this pressure to do more with less, a new way of working is starting to

#HLTHEurope is here! Tomorrow morning, our Chief Diagnostics Officer Meriem Sefta will be on stage tackling one of the biggest questions in healthcare: can AI really reinvent drug development and diagnostics? She’ll be sharing real-world examples of how it’s already happening,

There’s still time to join expert pathologist Magali Lacroix-Triki (Gustave Roussy), and Valentin Gaury, Owkin senior data scientist for our upcoming webinar: ‘Breast Cancer Recurrence Risk Assessment from Digitized H&E with RlapsRisk® BC, a Clinically Validated AI Prognostic

🎬 Excited to share our latest video highlighting PortrAIt's journey in transforming digital pathology and building a center of excellence in AI for oncology! After two years of intensive collaboration, we're proud to showcase the consortium’s key achievements: • Launch of

For our new Partners in Science film, William Jarnagan, Leslie Blumgart Chair in Surgery from Memorial Sloan Kettering Cancer Center discusses how AI can change the treatment of intrahepatic cholangiocarcinoma for the better. Owkin and MSK Cancer Center are partnering to bring together all the

🚀 Progress update from our AI for Glioblastoma Hackathon! Last Friday, teams and organizers from Owkin and Servier came together for an inspiring meeting to review the outstanding progress made by the winning teams since February’s 2-day hackathon in Paris. We’re thrilled to

Our VP of Product, Thea Backlar, spoke yesterday at the launch of the Amazon Web Services Health AI Hub, a new initiative helping healthcare organisations across Europe, the Middle East and Africa adopt and build AI tools with greater ease. Thea joined other healthcare leaders to explore

🎙️ Our Talent Director, Helen Burns, recently sat down with the Talk Talent to Me podcast to chat about her journey to Owkin. In this episode, Helen shares her path to leadership, her thoughts on building high performing teams, and why a strong company culture isn’t just a